Michael R. Bristow - Pres. & Chief Executive Offic, Director at ARCA biopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Pres. & Chief Executive Offic, Director
Stock Symbol
ABIO on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael R. Bristow since 7/7/2023

Holdings reported by Michael R. Bristow for ARCA biopharma, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 2,285 $5.71 K $2.50 Dec 14, 2021 Direct
Common Stock 1,414 $3.54 K $2.50 Dec 14, 2021 By NFS Custodian for Michael Bristow's IRA
Common Stock 1,109 $2.77 K $2.50 Dec 14, 2021 By InvestocorTrust as sole Trustee
Stock Option (right to buy) 95,000 Dec 14, 2021 Direct Common Stock

Transactions reported by Michael R. Bristow for ARCA biopharma, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership